GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Return-on-Tangible-Asset

NKY Medical Holdings (SZSE:300109) Return-on-Tangible-Asset : 13.58% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. NKY Medical Holdings's annualized Net Income for the quarter that ended in Mar. 2024 was ¥486 Mil. NKY Medical Holdings's average total tangible assets for the quarter that ended in Mar. 2024 was ¥3,575 Mil. Therefore, NKY Medical Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 13.58%.

The historical rank and industry rank for NKY Medical Holdings's Return-on-Tangible-Asset or its related term are showing as below:

SZSE:300109' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.29   Med: 8.02   Max: 14.6
Current: 14.38

During the past 13 years, NKY Medical Holdings's highest Return-on-Tangible-Asset was 14.60%. The lowest was 2.29%. And the median was 8.02%.

SZSE:300109's Return-on-Tangible-Asset is ranked better than
89.72% of 1080 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs SZSE:300109: 14.38

NKY Medical Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for NKY Medical Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Return-on-Tangible-Asset Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.54 2.29 7.78 8.82 14.60

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.71 17.36 16.96 10.05 13.58

Competitive Comparison of NKY Medical Holdings's Return-on-Tangible-Asset

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKY Medical Holdings's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's Return-on-Tangible-Asset falls into.



NKY Medical Holdings Return-on-Tangible-Asset Calculation

NKY Medical Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=493.027/( (3222.742+3529.973)/ 2 )
=493.027/3376.3575
=14.60 %

NKY Medical Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=485.548/( (3529.973+3620.377)/ 2 )
=485.548/3575.175
=13.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


NKY Medical Holdings  (SZSE:300109) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


NKY Medical Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines